Haensler; Jean

Patent Applications and Registrations

Patent applications and USPTO patent grants for Haensler; Jean.The latest application filed is for "human cytomegalovirus immunogenic composition".

Company Profile

2.20.25

Haensler; Jean - Grezieu la Varenne FR
Haensler; Jean - Grezieu-la-Varrene FR
Haensler; Jean - Pollionnay N/A FR
Haensler; Jean - Valency Pollionnay
Haensler, Jean - St. Genis les Ollieres FR
Haensler, Jean - Lyon FR
Haensler; Jean - Saint Genis les Ollieres FR
Haensler; Jean - San Francisco CA
Haensler; Jean - Petite Rosselle FR
Haensler; Jean - 57540 Petite-Rosselle FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Human cytomegalovirus immunogenic composition Grant 11,207,403 - Chaux , et al. December 28, 2	2021-12-28
Human Cytomegalovirus Immunogenic Composition App 20210023202 - Chaux; Pascal ; et al.	2021-01-28
Human Cytomegalovirus Immunogenic Composition App 20200276301 - Chaux; Pascal ; et al.	2020-09-03
Novel immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants App 20170360923 - Rigaut; Guillaume ; et al.	2017-12-21
Detoxification method for lipopolysaccharide (LPS) or lipid A of Gram-negative bacteria App 20170326221 - Haensler; Jean ; et al.	2017-11-16
Vaccine composition with aluminium hydroxide nanoparticles Grant 9,770,505 - Mathieu , et al. September 26, 2	2017-09-26
Immunogenic Compositions App 20160367655 - Gallichan; Scott ; et al.	2016-12-22
Thermoreversible oil-in-water emulsion Grant 9,504,659 - Klucker , et al. November 29, 2	2016-11-29
Immunogenic compositions Grant 9,327,021 - Gallichan , et al. May 3, 2	2016-05-03
Vaccine Composition With Aluminium Hydroxide Nanoparticles App 20140234422 - Mathieu; Yannick ; et al.	2014-08-21
Immunogenic Compositions App 20130344109 - Gallichan; Scott ; et al.	2013-12-26
Method for adjuvanting lipopolysaccharide (LPS) of Gram-negative bacteria App 20130295164 - Haensler; Jean ; et al.	2013-11-07
Method for adjuvanting lipopolysaccharide (LPS) of gram-negative bacteria Grant 8,506,971 - Haensler , et al. August 13, 2	2013-08-13
Meningococcal Vaccine Based on Lipooligosaccharide (LOS) and Neisseria Meningitidis Protein App 20120156281 - Haensler; Jean ; et al.	2012-06-21
Method for adjuvanting lipopolysaccharide (LPS) of Gram-negative bacteria App 20110014272 - Haensler; Jean ; et al.	2011-01-20
Detoxification method for lipopolysaccharide (LPS) or lipid A of gram-negative bacteria App 20100291192 - Haensler; Jean ; et al.	2010-11-18
Immunostimulant Composition Comprising At Least One Toll-Like Receptor 7 Or Toll-Like Receptor 8 Agonist And A Toll-Like Receptor 4 Agonist App 20100247557 - Burdin; Nicolas ; et al.	2010-09-30
Vaccine composition Grant 7,767,658 - Haensler August 3, 2	2010-08-03
Vaccine Composition App 20080131446 - Haensler; Jean	2008-06-05
Vaccine composition Grant 7,344,720 - Haensler March 18, 2	2008-03-18
Thermoreversible Oil-In-Water Emulsion App 20070191314 - Klucker; Marie-Francoise ; et al.	2007-08-16
Immunostimulant composition comprising at least one toll-like receptor 7 or toll-like receptor 8 agonist and a toll-like receptor 4 agonist App 20070087009 - Burdin; Nicolas ; et al.	2007-04-19
Vaccine composition App 20050208060 - Haensler, Jean	2005-09-22
Pharmaceutical composition for immunization against AIDS App 20050118188 - Dalenccon, Francois ; et al.	2005-06-02
Adjuvant for vaccine composition App 20050002952 - Haensler, Jean ; et al.	2005-01-06
Adjuvant for a vaccine composition Grant 6,780,421 - Haensler , et al. August 24, 2	2004-08-24
Vaccine composition App 20040038922 - Haensler, Jean ; et al.	2004-02-26
Immunological combinations for prophylaxis and therapy of helicobacter pylori infection App 20040033240 - Guy, Bruno ; et al.	2004-02-19
Pharmaceutical composition for immunisation against aids App 20030190326 - Dalenccon, Francois ; et al.	2003-10-09
Immunostimulant emulsion Grant 6,610,308 - Haensler August 26, 2	2003-08-26
Human cytomegalovirus DNA constructs and uses therefor App 20030120060 - Gonczol, Eva ; et al.	2003-06-26
Self-assembling polynucleotide delivery system Grant 6,300,317 - Szoka, Jr. , et al. October 9, 2	2001-10-09
Methods for inducing a mucosal immune response Grant 6,126,938 - Guy , et al. October 3, 2	2000-10-03
Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug Grant 6,124,270 - Haensler September 26, 2	2000-09-26
Self-assembling polynucleotide delivery system comprising dendrimer polycations Grant 6,113,946 - Szoka, Jr. , et al. September 5, 2	2000-09-05
Self-assembling polynucleotide delivery method Grant 5,977,084 - Szoka, Jr. , et al. November 2, 1	1999-11-02
Self-assembling polynucleotide delivery system Grant 5,955,365 - Szoka, Jr. , et al. September 21, 1	1999-09-21
Self-assembling polynucleotide delivery system comprising dendrimer polycations Grant 5,661,025 - Szoka, Jr. , et al. August 26, 1	1997-08-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.